NeuroSense Therapeutics Analyst Ratings
NeuroSense Therapeutics Analyst Ratings
While ratings are subjective and will change, the latest NeuroSense Therapeutics (NRSN) rating was a initiated with a price target of $0.00 to $7.50. The current price NeuroSense Therapeutics (NRSN) is trading at is $1.40, which is within the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 07/17/2023 | 435.71% | Alliance Global Partners | → $7.5 | Initiates Coverage On | → Buy |
| 01/07/2022 | 400% | Maxim Group | → $7 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 07/17/2023 | 435.71% | 聯盟全球合作伙伴 | → 7.5 美元 | 啓動覆蓋開啓 | → 購買 |
| 2022 年 7 月 1 日 | 400% | Maxim 集團 | → 7 美元 | 啓動覆蓋開啓 | → 購買 |
What is the target price for NeuroSense Therapeutics (NRSN)?
NeuroSense Therapeutics（NRSN）的目標價格是多少？
The latest price target for NeuroSense Therapeutics (NASDAQ: NRSN) was reported by Alliance Global Partners on July 17, 2023. The analyst firm set a price target for $7.50 expecting NRSN to rise to within 12 months (a possible 435.71% upside). 1 analyst firms have reported ratings in the last year.
聯盟全球合作伙伴於2023年7月17日公佈了NeuroSense Therapeutics（納斯達克股票代碼：NRSN）的最新目標股價。這家分析公司將目標股價定爲7.50美元，預計NRSN將在12個月內升至435.71％（可能上漲435.71％）。去年有1家分析公司公佈了評級。
What is the most recent analyst rating for NeuroSense Therapeutics (NRSN)?
分析師對NeuroSense Therapeutics（NRSN）的最新評級是多少？
The latest analyst rating for NeuroSense Therapeutics (NASDAQ: NRSN) was provided by Alliance Global Partners, and NeuroSense Therapeutics initiated their buy rating.
NeuroSense Therapeutics（納斯達克股票代碼：NRSN）的最新分析師評級由聯盟全球合作伙伴提供，NeuroSense Therapeutics啓動了買入評級。
When is the next analyst rating going to be posted or updated for NeuroSense Therapeutics (NRSN)?
NeuroSense Therapeutics（NRSN）的下一個分析師評級何時公佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of NeuroSense Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for NeuroSense Therapeutics was filed on July 17, 2023 so you should expect the next rating to be made available sometime around July 17, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括瀏覽公開財務報表，與NeuroSense Therapeutics的高管和客戶交談，以及聽取財報電話會議。大多數分析師每三個月進行一次評級，因此每家公司每年應該獲得4個評級。NeuroSense Therapeutics的最後一次評級是在2023年7月17日提交的，因此你應該預計下一個評級將在2024年7月17日左右公佈。
Is the Analyst Rating NeuroSense Therapeutics (NRSN) correct?
分析師對 NeuroSense Therapeutics (NRSN) 的評級是否
While ratings are subjective and will change, the latest NeuroSense Therapeutics (NRSN) rating was a initiated with a price target of $0.00 to $7.50. The current price NeuroSense Therapeutics (NRSN) is trading at is $1.40, which is within the analyst's predicted range.
雖然評級是主觀的，會發生變化，但最新的NeuroSense Therapeutics（NRSN）評級是最初的，目標股價爲0.00美元至7.50美元。NeuroSense Therapeutics（NRSN）目前的交易價格爲1.40美元，在分析師的預測區間內。
譯文內容由第三人軟體翻譯。